Yahoo
Taiwan - Delayed Quote TWD

Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW)

56.70 -0.20 (-0.35%)
At close: October 30 at 1:30:16 PM GMT+8
Chart Range Bar
Loading chart for 1720.TW
  • Previous Close 56.90
  • Open 57.20
  • Bid 56.70 x --
  • Ask 56.90 x --
  • Day's Range 56.40 - 57.20
  • 52 Week Range 50.18 - 60.55
  • Volume 218,708
  • Avg. Volume 226,381
  • Market Cap (intraday) 11.145B
  • Beta (5Y Monthly) -0.00
  • PE Ratio (TTM) 11.43
  • EPS (TTM) 4.96
  • Earnings Date (est.) --
  • Forward Dividend & Yield 2.00 (3.51%)
  • Ex-Dividend Date Jul 23, 2026
  • 1y Target Est --

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products. Further, it is involved in the manufacture and sale of active pharmaceutical ingredients, as well as veterinary drugs; and sales of medical devices and infant milk powder. It also exports its products. The company was incorporated in 1967 and is headquartered in Tainan City, Taiwan.

www.standard.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

1720.TW
9.69%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
56.10%

1-Year Return

1720.TW
16.41%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
59.83%

3-Year Return

1720.TW
15.08%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
179.95%

5-Year Return

1720.TW
100.91%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
166.15%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY25
Revenue 1.77B
Earnings --
Profit Margin 0.00%

Q3

FY24

Q1

FY25

Q2

FY25

Q3

FY25

0
500M
1B
2B
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.51%

  • Return on Assets (ttm)

    7.59%

  • Return on Equity (ttm)

    15.39%

  • Revenue (ttm)

    7.08B

  • Net Income Avi to Common (ttm)

    1.03B

  • Diluted EPS (ttm)

    4.96

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.32B

  • Total Debt/Equity (mrq)

    8.53%

  • Levered Free Cash Flow (ttm)

    464.13M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: